Cipla's US Milestone Gets The Street Talking. Analysts See Bigger Opportunity Ahead
Cipla said it has received US FDA approval for its Abbreviated New Drug Application (ANDA) for generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) across all three dosage...
\